Addition of angiogenesis inhibitors to CDK4/6 inhibitors and fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer

Chinese Medical Journal · Published 2026-07-07 · DOI 10.1097/cm9.0000000000004191

Free full text

Authors (14)

Mengwei Zhang, Limin Niu, Huimin Lyu, Zhenzhen Liu, Huiai Zeng, Zhenduo Lu, Xiuchun Chen, Jianghua Qiao, Peng Yuan, Shengnan Zhao, Huihui Sun, Jing Wang, Yajing Feng, Min Yan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhang, M., Niu, L., Lyu, H., et al. (2026). Addition of angiogenesis inhibitors to CDK4/6 inhibitors and fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer. Chinese Medical Journal. https://doi.org/10.1097/cm9.0000000000004191

Related articles